Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups

. 2025 Jul 08 ; 9 (13) : 3336-3339.

Status In-Process Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39993233

Department of Emergency Medicine University Hospital Berlin Berlin Germany

Department of Hematology and Medical Oncology Uniklinikum Erlangen Erlangen Germany

Department of Hematology and Oncology University Hospital Frankfurt am Main Frankfurt am Main Germany

Department of Hematology and Stem Cell Transplantation University Hospital Essen Essen Germany

Department of Hematology Oncology and Palliative Medicine Robert Bosch Hospital Stuttgart Germany

Department of Hematology Oncology and Rheumatology University Hospital Heidelberg Heidelberg Germany

Department of Internal Medicine 2 University Hospital Würzburg Würzburg Germany

Department of Internal Medicine Hematology and Oncology University Hospital Brno and Masaryk University Brno Brno Czech Republic

Department of Medicine 1 University Hospital Carl Gustav Carus TU Dresden Dresden Germany

Department of Medicine 3 University Hospital Munich Munich Germany

Department of Medicine A University Hospital Münster Münster Germany

Department of Oncology Hematology and Bone Marrow Transplantation with Division of Pneumology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Pathology University Hospital Munich Munich Germany

Department of Radiology University Hospital Munich Munich Germany

Gene Centre Munich Germany

German Cancer Research Centre Helmholtz Association and German Centers for Health Research Heidelberg Germany

Institute for Medical Information Processing Biometry and Epidemiology IBE LMU Munich Munich Germany

Partner Site Munich German Cancer Consortium Munich Germany

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Možnosti archivace